Skip to main content
Equibles
TARS logo

TARS · Tarsus Pharmaceuticals, Inc. · Analyst Estimates

Track TARS — free

Use TARS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TARS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$82.45 +1.33 (+1.64%)
Russell 2000 member Rebalance outlook locked
Market Cap
$3.63B
Shares
43.88M

Analyst Estimates

Compare analyst forecasts for Tarsus Pharmaceuticals, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1819790 CUSIP 87650L103 13F (30d) 152 filings 152 filers Visit website Investor relations